Based on a Cardiac Safety Research Consortium Think Tank held in October 2017 on “Detection, Assessment, and Risk Mitigation of Cardiac Safety Signals in Oncology Drug Development, this publication discusses emerging cardio-oncology nuances and the latest regulatory thinking on ways to manage risks.
Request a Genetics in Clinical Trials training session
What You'll LearnMost Recent Flipbooks
Placebo Response Reduction and Accurate Pain Reporting Training Reduces Placebo Responses
WIRB-Copernicus IRB Announces New Program to Facilitate IRB Review of Research Protocols for COVID-19 (Coronavirus) Vaccines and Therapies
Basket Clinical Trial Designs The Key to Testing Innovative Therapies is Innovation in Study Design and Conduct
Driving High Performance - Shortening study start-up and optimizing revenue generation
